Colin Quinn

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 505 citations · Full text

Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>

Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson et al. · Muscle & Nerve · 2020 · 174 citations · Full text

Outbreak of Variant Influenza A(H3N2) Virus in the United States

Michael A. Jhung, Scott Epperson, Matthew Biggerstaff et al. · Clinical Infectious Diseases · 2013 · 170 citations · Full text

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Benedikt Schoser, Mark Roberts, Barry J. Byrne et al. · The Lancet Neurology · 2021 · 124 citations

Clinical Trials, Cipaglucosidase Alfa, Pharmacotherapy +2

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies

Elisabeth Burnor, Li Yang, Hao Zhou et al. · Neurology · 2017 · 107 citations · Full text